With the goal of improving treatment for mesothelioma, a lethal asbestos-related cancer, the Mesothelioma Applied Research Foundation has announced that it will be holding the Second International Symposium on Malignant Mesothelioma in Las Vegas at the Caesars Palace convention center on October 6 through 8.
Mesothelioma is a malignant tumor that most commonly develops in the linings of the lungs, abdomen and heart. The research to find the cure for mesothelioma has been under way for decades and a
lot of progress has been made over the last few years. The Mesothelioma Applied Research Foundation, a non-profit organization whose goal is to put an end to mesothelioma as a life-threatening disease, has established an annual symposium to review and communicate such progress. Similarly to last year?s symposium, this year?s agenda includes valuable information for the patient and advocacy communities as well as presentations by the leading specialists in mesothelioma treatment.
The symposium will begin with the presentation outlining the scope of the disease and the threat it still brings to the community. It will be held by Dr. Stephen Levin from the well-known Mount Sinai Irving Selikoff Center for Occupational and Environmental Medicine, a renowned author and Pulitzer winner Andrew Schneider, as well as mesothelioma experts Michael Harbut and Michele Carbone.
Lectures held specifically for patients and their families will cover many aspects of mesothelioma treatment such as surgery, chemotherapy, pain management as well as other newly developed treatments. Additionally, emotional, physical and psychological aspects of the disease will be covered as well as their effect on patients and caregivers.
Some other scientific topics covered at the symposium will include early detection, and diagnostics of the disease. Treatment options such as surgery, radio and chemotherapy will be covered for both peritoneal and pleural mesothelioma types. Chemotherapy options will also be covered including such topics as Alimta/Cisplatin treatment. Novel treatment approaches will be presented including some of the new developments in scientific research against the disease. Attending medical professionals will receive CME credits for these sessions, however, all are welcome to attend.
The Mesothelioma Applied Research Foundation will award its Pioneer Awards to those organizations investing in mesothelioma research. In addition, the winner of the annual "Congressman Bruce Vento Hope Builder Award" established by MARF will be announced
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment